Jackson Creek Investment Advisors LLC acquired a new position in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 135,198 shares of the company's stock, valued at approximately $1,466,000. Jackson Creek Investment Advisors LLC owned approximately 0.10% of AdaptHealth as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. GAMMA Investing LLC increased its position in shares of AdaptHealth by 175.2% in the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after acquiring an additional 4,758 shares in the last quarter. Guggenheim Capital LLC increased its position in shares of AdaptHealth by 10.1% in the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after acquiring an additional 1,525 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of AdaptHealth in the fourth quarter valued at $169,000. Humankind Investments LLC boosted its stake in shares of AdaptHealth by 18.3% in the fourth quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock valued at $171,000 after purchasing an additional 2,776 shares during the period. Finally, Proficio Capital Partners LLC purchased a new position in shares of AdaptHealth in the fourth quarter valued at $181,000. Institutional investors and hedge funds own 82.67% of the company's stock.
AdaptHealth Stock Up 0.8%
NASDAQ AHCO traded up $0.07 during trading hours on Friday, reaching $9.27. 92,206 shares of the company traded hands, compared to its average volume of 1,473,219. AdaptHealth Corp. has a 12 month low of $7.11 and a 12 month high of $11.90. The company has a current ratio of 1.29, a quick ratio of 1.07 and a debt-to-equity ratio of 1.25. The stock has a market capitalization of $1.25 billion, a PE ratio of 16.26, a PEG ratio of 1.06 and a beta of 1.63. The company has a 50 day moving average of $8.98 and a two-hundred day moving average of $9.40.
Analyst Ratings Changes
AHCO has been the subject of several analyst reports. Royal Bank Of Canada decreased their target price on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a research note on Thursday, May 8th. Truist Financial decreased their target price on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research note on Monday, May 12th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $13.40.
Get Our Latest Analysis on AdaptHealth
AdaptHealth Profile
(
Free Report)
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AdaptHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.
While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.